Popular Articles
Cellulite Cream

Revealing Leukemia-Initiating Cells
Two new studies reveal a way to increase the body"s appetite for gobbling up the cancer stem cells responsible for acute myeloid leukemia (AML), a form of cancer with a particularly poor survival rate. The key is targeting a protein on the surface of those cells that sends a "don"t eat me" signal to the macrophage immune cells that serve as a first line of defense, according to the reports in the July 24th issue of the journal Cell, a Cell Press publication.
generic viagra online
Ligand Initiates Clinical Trial With The Selective Androgen Receptor Modulator LGD-4033, A Potential Treatment Of Muscle And Bone Disorders
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced the initiation of a Phase I clinical trial with LGD-4033, a next-generation selective androgen receptor modulator (SARM) designed to provide the benefits of androgen receptor stimulation on skeletal muscle and bone without the side effects of currently marketed androgens. The Phase I study will evaluate the safety, tolerability and pharmacokinetic profile of orally administered LGD-4033.
News of the day
They Are Young And Need The Job: A Second Chance For Dangerous T-cells
The immune system"s T-cells react to foreign protein fragments and therefore are crucial to combating viruses and bacteria. Errant cells that attack the body"s own material are in most cases driven to cell death. Some of these autoreactive T-cells, however, undergo a kind of reeducation to become "regulatory T-cells" that keep other autoreactive T-cells under control. A group led by immunologist Professor Ludger Klein of LMU Munich has now shown that the developmental stage of an autoreactive T-cell is decisive to its ultimate destiny. Young autoreactive T cells are very readily reeducated into regulatory T-cells. Under identical conditions, however, older T cells become fully activated and can cause damage they are in a way resistant to reeducation. "We now intend to study at the molecular level what makes a T-cell accessible for reeducation," said Klein, "because then it may be possible to convert even normal adult T-cells, which can be obtained easily and in great numbers from blood. Possibly, they could then be used as regulatory T-cells in therapies for autoimmune diseases such as type-1 diabetes or multiple sclerosis: these are diseases that are triggered by uncontrolled autoreactive T-cells." (PNAS, 10 June 2009)
Nutrition

Increasing ICS Compliance: The Voice May Be Recorded, But The Results Are Real

Automated phone calling may help physicians solve a perennial problem: patients who don"t take medicine prescribed for chronic health conditions. Researchers at the Kaiser Permanente Center for Health Research, in Portland, Oregon, tested an automated calling service designed to encourage patients with asthma to fill or refill their prescriptions for inhaled corticosteroids (ICS). The research was presented on May 17 at the 105th International Conference of the American Thoracic Society in San Diego. "The trial demonstrated a modest, but statistically significant, improvement in compliance," said William M. Vollmer, Ph.D., senior investigator at the center, who led the trial. "And even a small change in adherence can potentially produce a big public health benefit, especially when the disease is as prevalent as asthma." According to the National Heart, Lung, and Blood Institute, about 22 million Americans have asthma, most need to take medicine daily for long-term control of the disease and ICS are the preferred medicines for gaining that control. The 18-month-long trial involved approximately 8,600 members enrolled in the integrated health system in the Northwest United States and Hawaii. Member participants were randomized to usual care and to the phone calling system. The study found that the calls increased estimated medication adherence two percent beyond the compliance of patients receiving usual care (40 percent versus 38 percent; p


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):